Arrhythmias Flashcards
Class I Anti-Arrhythmics
Na Blockers - disopyramide, lidocaine, flecainide
Class I Anti-Arrhythmics CI/warnings
CI- severe asthma/COPD
warning: structural/ ischeamic HD
Class II Anti-Arrhythmics
B blockers
Class III Anti-Arrhythmics
K Blockers - amiodarone, sotalol, dronedarone
Dronedarone ADRs
Hepatotox and HF
Class IV Anti-Arrhythmics
Rate lim. CCBs (Dil & Ver)
Other Anti-Arrhythmics
Digoxin (sedentary non-pAF, cong HF), adenosine
Electro or Pharmo Cardioversion
Pharmo must be w/i 48h of symptoms or inc risk of stroke. Electro preferred if >48hrs post symptoms (wait 3 wks post anticoag, wait 4 wks post cardioversion before stopping anticoag.) If heamodynamically unstable, electocardioversion (give parenteral antiocoag & rule out atrial thrombus before procedure)
AF Maintenance
1st line rate (B blocker, rate lim CCB, digoxin)
Monotherapy-> dual therapy -> rhythm control
Rhythm control- B blockers, antiarythmics
Pill in pocket (anti-arryhthmics eg flecanide) for infrequent episodes of pAF.
New onset AF
W/ life threatening heamodynamic instability- electrocarioversion
W/o life threatening heamodynamic instability:
<48hrs - rate/rhythm control (electrical or amiodarone/flec)
>48hrs - rate control only (verapamil or B blocker)
AF stroke prevention
anticoag if stroke risk (CHA2DS2VASc) >bleed risk (HAS-BLED)
give anticoag if score 2 or more on chadsvasc, no anticoag req if man=0 or woman=1
CHA2DS2VASc
C- chronic HF/LVD H- hypertension A2- Age 75+ D- diabetes S- stroke/tia/VTE history V- vascular disease A- age 65-74 Sc - Sex category
Ventricular tachycardias immediate treatment
Pulseless/fib - immediate defib and CPR
unstable sustained: direct current cardioversion (repeat w/ amiodarone if unsuccessful)
Stable sustained : IV amiodarone
Unsustained : B blocker
Ventricular tachycardias maintenance
High risk of cardiac arrest
Most patients require defib implant
some also require drugs - sotalol, B-Blocker (w/ or w/o amiodarone)
Torsades de Pointes (QT prolongation)
Treatment: Magnesium sulphate
Causes: Sotalol and other QT prolongers, hypokal, bradycardia.
Amiodarone ADRs: skin
slate grey skin, phytotoxicity (counsel to cover skin and use sun cream for months after finishing amiodarone)
Amiodarone ADRs: eyes
Corneal deposits (counsel- night time glare whilst driving), optic neuropathy leading to blindness (couple to stop if any vision disturbances/loss)
Amiodarone ADRs: nerves
Peripheral neuropathy (counsel- may feel tingling etc in extremities)
Amiodarone ADRs: lungs
pneumonitis, pulmonary fibrosis (counsel- look for SOB, dry cough)
Amiodarone ADRs: liver
hepatotoxicity (counsel- signs of hepatotox, inc. itching, jaundice, signs of bleeding, etc)
Amiodarone ADRs: Thyroid
Hyper (weight loss, heat intolerance, tachycardia), start carbimazole, stop amiodarone
Hypo (weight gain, cold intolerance, bradycardia), starts levothyroxine if necessary, w/o w/d amiodarone
Amiodarone monitoring
annual eye test, chest X-ray before starting, LFTs 6/12, TFTs 6/12, BP, ECG, U&Es (K+).
amiodarone interactions
enzyme inhibitor, so reduced doses may be required for warfarin, phenytoin, digoxin required half m=normal dose
Inc risk of myopathy with statins
Bradycardia, AV block, myocardial depression with B blockers, and Rate lim CCBs
QT prolongation- other drugs include quinolones, macrolides, TCAs, (es)citalopram, quinine and analogues, antipsychotics, fluconazole
Digoxin MOA
Increases myocardial force of contraction (+ inotrope), reduces AVN conduction (- chronotrope)
Digoxin Therapeutic levels &monitoring
1-2mcg/l (6h after dose). Monitoring only required with signs of toxicity and renal impairment
Amiodarone loading dose
200mg TDS 7/7 then BD 7/7 then OD
Digoxin maintenance dose
AF 125-250mcg, worsening/sever HF (in sinus) 62.5-125mcg
Digoxin signs of toxicity
Slow and sick Bradycardia/heart block Nausea, V&D Abdo pain Yellow/blurred vision confusion, delirium, rash
Digoxin toxicity risk
low K, Mg, high Ca, hypoxia, renal impairment
Digoxin toxicity treatment
Withdraw dig, treat electrolyte imbalances, digital for life threatening vent. arrhythmia if atropine not successful
Digoxin interactions
Drugs causing hypokalaemia (inc risk of toxicity) eg thiazide/loop diuretics, b agonists, steroids, theophylline.
Enzyme inhibitors (inc risk of toxicity): eg amiodarone, fluconazole, SSRIs
Enzyme inhibitors (sub therapeutic): eg SJW, rifampicin
Nephrotoxics (reduce digoxin clearance) eg NSAID, ACE?ARBs